上海劲威:源于法国巴斯德研究所慢病毒载体技术的新药研发和CMO生产平台。致力于Bestin的传染病生物药和新生抗原癌症个性化疗法。已经完成乙肝和肝癌的动物概念性验证,将于2020年进行传染病生物药IND申报和个性化新生抗原生物技术的研究者研究
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows